首页> 美国卫生研究院文献>Journal of Translational Medicine >In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
【2h】

In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells

机译:白介素(IL)-1β抑制对肾小管和肝星状细胞上皮-间质转化(EMT)的体外影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe epithelial to mesenchymal transition (EMT) is a multi-factorial biological mechanism involved in renal and hepatic fibrosis and the IL-1 beta has been assumed as a mediator of this process although data are not exhaustive. Therefore, the aim of our study was to evaluate the role of this cytokine in the EMT of renal proximal tubular epithelial cells (HK-2) and stellate cells (LX-2) and the protective/anti-fibrotic effect of its inhibition by Canakinumab (a specific human monoclonal antibody targeted against IL-1beta).
机译:背景上皮向间质转化(EMT)是一种参与肾脏和肝纤维化的多因素生物学机制,尽管数据并不详尽,但IL-1β已被认为是该过程的媒介。因此,我们的研究目的是评估该细胞因子在肾近端肾小管上皮细胞(HK-2)和星状细胞(LX-2)的EMT中的作用,以及Canakinumab对其抑制的保护/抗纤维化作用。 (针对IL-1beta的特异性人单克隆抗体)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号